Clinical Trial
Randomized trial of therapy with platelet antiaggregants for threatened stroke
- PMID: 6989457
- PMCID: PMC1801847
Item in Clipboard
Clinical Trial
Randomized trial of therapy with platelet antiaggregants for threatened stroke
Can Med Assoc J.
.
No abstract available
Similar articles
-
Summary of design features: clinical trials of platelet-active drugs in cerebrovascular disease.Circulation. 1980 Dec;62(6 Pt 2):V88-9. Circulation. 1980. PMID: 7002355 Clinical Trial.
-
Present status of antiaggregating agents in coronary and cerebrovascular disease prevention.Haematologica. 1980 Jun;65(3):361-9. Haematologica. 1980. PMID: 6778788 Review. No abstract available.
-
Trials of antiplatelet drugs: some methodological considerations.Rev Epidemiol Sante Publique. 1979 Sep 18;27(2):87-90. Rev Epidemiol Sante Publique. 1979. PMID: 538303 No abstract available.
-
Prevention of stroke.Int Anesthesiol Clin. 1984 Fall;22(3):11-29. Int Anesthesiol Clin. 1984. PMID: 6384054 Clinical Trial. No abstract available.
-
Does platelet antiaggregant therapy lessen the severity of stroke?Neurology. 1985 May;35(5):632-6. doi: 10.1212/wnl.35.5.632. Neurology. 1985. PMID: 3887210 Review.
Cited by
-
Plasma drug and antiplatelet profiles of the original acetylsalicylic acid preparations used in the AMIS, PARIS and German-Austrian trials for secondary prevention of myocardial infarction.Eur J Clin Pharmacol. 1988;33(6):541-7. doi: 10.1007/BF00542484. Eur J Clin Pharmacol. 1988. PMID: 3366158
-
Plasma salicylate levels and platelet function after acute and chronic administration of slow-release acetylsalicylic acid (Monobeltin).Eur J Clin Pharmacol. 1985;27(6):683-7. doi: 10.1007/BF00547049. Eur J Clin Pharmacol. 1985. PMID: 3987774
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources